See our platform for other disorders
×

Evidence-Based Interventions for bipolar disorder (EBI-BD)

EBI-BD is a project developed following the U-REACH framework. More information on the U-REACH framework can be found here.
Rank medication

Brief words about EBI-BD

What is EBI-BD ?
EBI-BD is an open-access platform storing current best scientific evidence about the efficacy and acceptability of interventions for people with bipolar disorder.
View database
For clinical guideline makers.
This EBI-BD database aims to inform evidence-based guidelines by facilitating access to updated results of a systematic umbrella review of the scientific literature on interventions for bipolar disorder, and to provide a description of all the pharmacological options, other biological treatments and psychosocial interventions tested in randomized controlled trials and pooled in (network) meta-analyses. When using EBI-BD to inform evidence-based clinical guidelines, an additional systematic literature search should be conducted to identify recent individual RCTs that have not been pooled in any meta-analysis yet.
View interventions
For persons with BD and families.
The EBI-BD database also provides links to existing psychoeducation materials, that are made freely available from other groups, organizations, institutions, or associations
View materials

Project leaders

Marco Solmi, MD, PhD
University of Ottawa
Charité University Medicine
 
Marco Solmi is Associate Professor of Psychiatry at University of Ottawa. His clinical focus is on prevention/early intervention for mental disorders, physical health in mental disorders, and psychopharmacology. He ranks #5 worldwide in terms of expertise in systematic reviews and meta-analysis according to Expertscape. He is also listed among the top 0.1% most cited researchers in the field of Psychology and Psychiatry.
Corentin J. Gosling, PhD
Université Paris Nanterre
Université Paris Cité
University of Southampton
Corentin Gosling is an Associate Professor of Neuropsychology at Université Paris Nanterre. He is also a visiting researcher at University of Southampton. His research interests focus on the dissemination of knowledge about interventions for mental disorders and developping new methodological and statistical tools for evidence synthesis.
Jess Fiedorowicz, MD, PhD
University of Ottawa
University of Iowa
 
Jess Fiedorowicz is Head and Chief of the Department of Mental Health at the Ottawa Hospital. Outside of his roles in Ottawa, he also serves as Editor-in-Chief of the Journal of Psychosomatic Research and as a member of the U.S. Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee.
Samuele Cortese, MD, PhD
University of Southampton
Solent NHS Trust
New York University
Samuele Cortese is currently Professor of Child and Adolescent Psychiatry at the University of Southampton and Honorary Consultant Child and Adolescent Psychiatry for Solent NHS Trust. He ranks #1 worldwide in terms of expertise on ADHD and #2 in child psychiatry according to Expertscape. He is also listed among the top 0.1% most cited researchers in the field of Psychology and Psychiatry.

Core members of the team

Michele De Prisco, MD, PhD
University of Barcelona
 
Michele De Prisco is a psychiatrist at the Bipolar and Depressive Disorders Unit (Hospital Clinic, Barcelona, Spain). His interests range from studying common psychopathological features (e.g., emotion dysregulation) to applying predictive models in psychiatry. His core skills include various aspects of meta-research and data analysis, with emphasis on methodological issues.
Joaquim Radua, MD, PhD
University of Barcelona
 
Dr. Radua, leader of the Imaging of Mood, Anxiety and Related Disorders (IMARD) link group at Institut d'Investigacions Biomèdiques August Pi i Sunyer link (IDIBAPS, Barcelona) and associate professor of the degree in Medicine at the University of Barcelona, is a psychiatrist and statistician who earned his doctorate in biostatistics of brain imaging at the Institute of Psychiatry, Psychology & Neuroscience link (IoPPN), King's College London.
Vincezo Oliva, MD, PhD
University of Barcelona
University of Bologna
Vincenzo Oliva is a psychiatrist and researcher at the Bipolar and Depressive Disorders Unit in Barcelona, Spain, and the Department of Biomedical and Neuromotor Sciences in Bologna, Italy. His focus is on affective disorders and precision psychiatry, utilizing neurobiological and environmental data for personalized diagnosis and treatment.
Alessandro Miola, MD
University of Padova
 
Alessandro Miola is a psychiatrist, and PhD. He trained at the University of Padua, Italy, and is a research fellow at the Department of Psychiatry and Psychology at Mayo Clinic (Rochester, MN, USA). His research interests encompass the neurobiological underpinnings of major mood disorders, particularly bipolar disorders, with emphasis on emotional processing, suicidal behavior, and clinical psychopharmacology.